On May 26, 2021, 1:00 p.m. – 2:30 p.m. (Eastern Time), NIMHD will host a preapplication technical assistance webinar to provide information and respond to questions from prospective applicants who plan to submit applications to RFA-MD-21-004, Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities.
ORWH staff members Pamela Stratton, M.D.; Elena Gorodetsky, M.D., Ph.D.; and Director Janine A. Clayton, M.D., FARVO, recently authored a commentary article in the Journal of the National Medical Association on the “collision of crises” between the COVID-19 pandemic and rising rates of maternal morbidity and mortality (MMM) in the United States.
Held each year during National Women’s Health Week (May 9–15, 2021), the symposium honors the first full-time director of ORWH.
On April 20, 2021, at 3:00‒4:00 p.m. ET, the NIH scientific interest group called Sex and Gender in Health and Disease will host a virtual talk on human microbiota by Rashmi Sinha, Ph.D., of the National Cancer Institute.
The Notice of Special Interest provides an opportunity for clinical trials and studies funded by the NIH Helping to End Addiction Long-term (HEAL) Initiative to address challenges of recruitment, retention, and engagement of populations suffering from pain and opioid use disorder.
On June 24, 2021, at 1:00–2:00 p.m. ET, ORWH will host “Analysis and Action: Applications of Intersectionality in COVID-19,” the second lecture in the “Diverse Voices: COVID-19, Intersectionality, and the Health of Women” speaker series.
NIH recently established the UNITE initiative to address structural racism and promote equitable representation and inclusion at NIH and throughout the larger biomedical research enterprise.
The publication describes how lockdowns and mitigation efforts disrupted global scientific conferences, laboratory research, work routines, and virtually every aspect of professional activity.
The new webpage includes an overview of scientific and policy priorities related to COVID-19 and its impact on maternal health.
AMP AIM will deepen the current understanding of autoimmune diseases—such as rheumatoid arthritis, lupus, psoriatic spectrum diseases, and Sjögren’s syndrome—which afflict more than 25 million Americans.
ORWH Associate Director for Basic and Translational Research Chyren Hunter, Ph.D., and Charles Hoeffer, Ph.D., Assistant Professor of Integrative Physiology at the University of Colorado Boulder, were interviewed by Ira Flatow for an episode of the “Science Friday” public radio program that aired on February 26, 2021.
The new site describes the history of the WgWBC and provides information on the working group’s subcommittees, supported programs, grants, career development resources, NIH diversity resources, and career flexibility initiatives.
NIH recently released three notices of special interest announcing funding opportunities supporting research on improving women’s health and maternal health, preventing maternal morbidity and mortality, developing new maternal health technologies, and understanding and addressing the impact of COVID-19 on maternal health.
To mark the publication of a special issue of the Journal of Women’s Health focused on the problem of maternal morbidity and mortality in the United States, on February 24, 2021, ORWH hosted a Twitter chat on issues related to maternal and obstetric health and safety.
A special issue of the Journal of Women’s Health (JWH) characterizes the increasing problem of maternal morbidity and mortality (MMM) in the United States.
NIH recently announced that F and K research grant recipients directly affected by COVID-19 may apply for no-cost extensions and funded extensions (NOT-OD-21-052).
In support of NIH efforts to research and mitigate the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ORWH recently released its own COVID-19 webpage.
ORWH, in collaboration with the National Institute of Diabetes and Digestive and Kidney Diseases, has released a notice of intent to publish (NOITP) a funding opportunity announcement (FOA) to help women attain leadership roles in scientific careers.
On February 11 at 3:00 p.m. ET, ORWH will host an informational webinar on the NIH Prize for Enhancing Faculty Gender Diversity in Biomedical and Behavioral Science.
NIH has launched a new website that provides the research community and the public with trusted, up-to-date, accurate information about research on COVID-19 at NIH and across the NIH-supported research community.
This extensive virtual environment includes video recordings from the meetings, scholarly posters from the symposium’s research presentations, informational videos about ORWH and its signature programs, historical information about ORWH, and other resources.
New research funded by the NIH HEAL Initiative seeks to understand the effects of opioid use during pregnancy on maternal and child health and behavioral outcomes.
December 21, 2020
On January 27, 2021 at 11 a.m. (Eastern), ORWH will launch a new virtual lecture series titled “Diverse Voices: COVID-19 and the Health of Women.”
December 21, 2022
ORWH recently expanded its e-learning course offerings with “Sex as a Biological Variable: A Primer” and the final two modules of the “Bench to Bedside: Integrating Sex and Gender to Improve Human Health” course.
On December 14–16, 2020, ORWH hosted a series of three virtual meetings in celebration of the office’s 30-year role in supporting women’s health research and sex and gender studies within and beyond the NIH scientific community.
December 18, 2020
A new website created by the U.S. Department of Health and Human Services (HHS) serves as a central resource for the public and health care providers to find information about different stages of COVID-19 illness, NIH-supported clinical trials to prevent and treat COVID-19, and locations to donate plasma.
On December 14, 2020, from 10:00 a.m. to 6:00 p.m. Eastern Time, the Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Annual Meeting will kick off the ORWH 30th Anniversary Virtual Meeting Series by bringing BIRCWH Scholars and senior faculty together to share research and career experiences.
On December 15, 2020, from 9:30 a.m. to 5:30 p.m. Eastern Time, the ORWH 30th Anniversary Scientific Symposium, titled “Advancing the Health of Women Through Science,” will feature.
On December 16, 2020, from 10:40 a.m. to 11:30 a.m. Eastern Time, the keynote address at the annual meeting of the Specialized Centers of Research Excellence on Sex Differences (SCORE) will be given, rounding out the ORWH 30th Anniversary Virtual Meeting Series.
ORWH is hosting three enlightening virtual meetings to celebrate 30 years of women’s health research and sex and gender studies within and beyond the NIH scientific community.
The administrative supplements support expansion of research in States that NIH has designated “IDeA States” to address important issues of women’s health, particularly maternal and infant mortality and morbidity.
Throughout the week of October 11–17, the U.S. Department of Health and Human Services (HHS) Office on Women’s Health (OWH) will introduce National Women’s Blood Pressure Awareness Week to increase awareness of blood pressure control for women of reproductive age.
U.S. life expectancy has decreased in recent years, a trend driven in large part by “deaths of despair”—suicides as well as fatalities related to alcohol and other drugs.
An estimated 700 women die each year in the U.S. from conditions related to or associated with pregnancy or childbirth (the highest rate among developed nations), and over 50,000 women experience severe maternal morbidity.
ORWH is now accepting applications for a Challenge Prize competition aimed at increasing gender diversity among faculty members at colleges and universities and removing barriers to the uptake of systemic institutional approaches for transformative change.
The NIH Maternal Morbidity and Mortality (MMM) web portal collects information about how women in the United States, particularly Black women, experience much higher rates of pregnancy-related injury, illness, and fatality than women in peer nations.
The Office of Disease Prevention and Health Promotion (ODPHP) of the U.S. Department of Health and Human Services (HHS) recently released Healthy People 2030, a plan that sets data-driven objectives for addressing the Nation’s most critical public health priorities.
ORWH Associate Director for Science Policy, Planning, and Analysis Samia Noursi, Ph.D.; ORWH Director Janine A. Clayton, M.D.; and colleagues recently published “The Intersection of "Maternal Morbidity and Mortality and Intimate Partner Violence in the United States."
On September 2, 2020, NIH will virtually host the Inclusion Across the Lifespan-II Workshop: Implementation and Future Directions.
On Tuesday, September 1, 2020, at 1:00 p.m. (Eastern Time), ORWH will host an hour-long webinar titled “Incorporating a Sex-and-Gender Lens from Bench to Bedside: Neurology,” featuring Farida Sohrabji, Ph.D., of Texas A&M College of Medicine.
On August 5, 2020, ORWH Director Janine A. Clayton, M.D., and ORWH Associate Director for Careers Xenia Tigno, Ph.D., hosted a Facebook Live panel discussion and Q&A session about leadership among women in STEMM.
As recent months have demonstrated, stress is unavoidable. Now more than ever, it’s important to understand stress and how we can manage it.
On July 22, 2020, ORWH hosted an online panel discussion titled “Improving Chronic Disease Outcomes Through Approaches that Address Social Determinants of Health.”
NIH recently released the NIH-Wide Strategic Plan for COVID-19 Research. The strategic plan describes five priorities for accelerating the development of therapeutic interventions, vaccines, and diagnostics.
NIH recently published a request for information (RFI) titled “Enhancing Rigor, Transparency, and Translatability to Improve Biomedical Research Involving Animal Models” (NOT-OD-20-130).
As part of its multifaceted response to the COVID-19 pandemic, NIH has launched an unprecedented four-pronged initiative, titled Rapid Acceleration of Diagnostics (RADx), to catalyze the scientific community to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.
The National Institute on Drug Abuse (NIDA) recently released Notice of Special Interest (NOSI): Research on Co-morbid Substance Use, Substance Use Disorders, and Other Psychiatric Disorders (NOT-DA-20-004).
The High-Risk, High-Reward Research program of the NIH Office of Strategic Coordination—The Common Fund offers four funding opportunities for outstanding, creative scientists at all career stages.
NIH has dedicated numerous resources to support research on the newly emerged coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The Study of Women’s Health Across the Nation (SWAN) helps scientists, health care providers, and patients understand the relationship between women’s midlife experiences, such as menopause, and their health and quality of life in later years.